{"id":3378,"date":"2023-07-13T22:31:54","date_gmt":"2023-07-13T20:31:54","guid":{"rendered":"https:\/\/jacked.sk\/obchod\/dsip-sleep-regeneration\/"},"modified":"2026-08-21T14:23:00","modified_gmt":"2026-08-21T12:23:00","slug":"dsip-sleep-regeneration","status":"publish","type":"product","link":"https:\/\/dev.jacked.sk\/en\/sleep-research\/dsip-sleep-regeneration\/","title":{"rendered":"DSIP 10 mg"},"content":{"rendered":"
\n\n\t
\n\t\t\t\t
\n\t\t\t\n\t\t\t\n

DSIP 10 mg \u2013 Delta Sleep-Inducing Peptide for Sleep Cycle Research<\/h2>\n

\u26a0\ufe0f Legal Notice:<\/strong> DSIP is intended exclusively for scientific and research purposes. It is not intended for human use as a medication, dietary supplement, or cosmetic product. Sale is restricted to individuals over the age of 18. <\/p>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n\t

\n\t\t\t\t
\n\t\t\t\n\t\t\t\n

What is DSIP?<\/h2>\n

DSIP (Delta Sleep-Inducing Peptide) is a nonapeptide composed of 9 amino acids<\/strong> with the sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. It is an endogenous peptide with a molecular weight of 848.8 Da that has been identified in brain tissue and cerebrospinal fluid. DSIP is one of a group of neurobiologically active peptides<\/strong> with a potential role in regulating sleep states and neuroendocrine processes. <\/p>\n

Unlike many synthetic research peptides, DSIP is of endogenous origin\u2014it was isolated directly from mammalian biological material. This fact makes it an interesting subject of research in terms of the natural regulatory mechanisms of sleep. <\/p>\n

Important: DSIP is not approved as a drug or dietary supplement<\/strong> in the European Union or elsewhere. All biological data are derived from in vitro and in vivo studies in animal models, or from preliminary human studies conducted in the 1970s and 1980s. <\/p>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n\t

\n\t\t\t\t
\n\t\t\t\n\t\t\t\n

History of the Discovery and Scientific Origins<\/h2>\n

DSIP was discovered in 1974<\/strong> by Prof. Marcello Monnier and colleagues<\/strong> at the University of Basel<\/strong> (Switzerland). Monnier and his team monitored electrical changes in the brains of cats following electrical stimulation of the thalamus and found that brain dialysate from the stimulated animals could induce delta sleep in other (unstimulated) individuals following intravenous administration. <\/p>\n

This groundbreaking study suggested the existence of an endogenous molecule responsible for initiating deep (delta) sleep. The subsequent isolation and characterization of this molecule led to the identification of a nonapeptide, which was named Delta Sleep-Inducing Peptide (DSIP)<\/strong>. <\/p>\n

In the 1980s, the DSIP was the subject of intense scientific interest, with research being conducted at several European and American institutions. Interest in DSIP is experiencing a resurgence in the context of modern research in neuroendocrinology and chronobiology. <\/p>\n

Source: Monnier M. et al., Pfl\u00fcgers Archiv (1977); Schoenenberger GA. et al., European Neurology (1978)<\/em><\/p>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n\t

\n\t\t\t\t
\n\t\t\t\n\t\t\t\n

Mechanism of Action in Research<\/h2>\n

Modulation of Delta Wave Activity (EEG)<\/h3>\n

The key research hypothesis centers on the ability of DSIP to modulate delta wave activity in the brain<\/strong>, as measured by electroencephalography (EEG). Delta waves (0.5\u20134 Hz) are characteristic of the deepest stage of non-REM sleep (N3), which is considered biologically essential for physical recovery, memory consolidation, and neuroendocrine regulation. <\/p>\n

Preclinical studies in animal models have documented an increase in the proportion of delta-wave sleep following DSIP administration. Interpreting these results in the context of human neuroscience requires further research. <\/p>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n\t

\n\t\t\t\t
\n\t\t\t\n\t\t\t\n

Interaction with the hypothalamic-pituitary-adrenal (HPA) axis<\/h2>\n

Research suggests that DSIP may interact with the hypothalamic-pituitary-adrenal (HPA) axis<\/strong> \u2014the primary neuroendocrine regulator of the stress response. The HPA axis regulates cortisol production via the CRH \u2192 ACTH \u2192 cortisol cascade. Some studies document the effect of DSIP on the rhythmic secretion of corticotropin and melatonin, placing it within the field of research on circadian rhythms and stress adaptation. <\/p>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n\t

\n\t\t\t\t
\n\t\t\t\n\t\t\t\n

Antinociceptive and Antioxidant Properties<\/h2>\n

In addition to sleep research, in vitro studies and animal models have shown potential antinociceptive properties<\/strong> of DSIP (reduction in pain perception), as well as preliminary results suggesting antioxidant activity. These areas are in the basic research stage and require confirmation in further studies. <\/p>\n

Sources: Kastin AJ. et al., Pharmacology, Biochemistry, and Behavior (1981); Khvatova EM. et al., Peptides (2003) <\/em><\/p>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n\t

\n\t\t\t\t
\n\t\t\t\n\t\t\t\n

DSIP Research Areas<\/h2>\n

Research on Sleep Cycles and Delta Activity<\/h3>\n

DSIP\u2019s primary area of research remains the modulation of sleep architecture, specifically the proportion and quality of delta (deep non-REM) sleep<\/strong>. Research protocols include polysomnography in animal models and correlational studies using EEG measurements. This area is relevant to research groups focusing on the neurobiology of sleep, chronobiology, and sleep disorder research. <\/p>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n\t

\n\t\t\t\t
\n\t\t\t\n\t\t\t\n

Regulation of the Stress Response and Cortisol<\/h3>\n

The interaction of DSIP with the HPA axis makes this peptide of interest for research into stress physiology<\/strong>. Studies are investigating its potential effects on basal and stress-induced cortisol secretion, as well as on the body\u2019s adaptation to repeated stressors. This research is relevant to the fields of neuropsychology and behavioral neuroscience. <\/p>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n\t

\n\t\t\t\t
\n\t\t\t\n\t\t\t\n

Preliminary research into other properties<\/h3>\n

The literature documents further research interest in DSIP in the following contexts:
– Modulation of the opiate system (interaction with opioid receptors in preclinical models)
– Effects on body temperature and thermoregulation
– Preliminary research in models of epileptic activity<\/p>\n

All of these areas are in the basic research stage, with insufficient data to support any generalizations.<\/p>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n\t

\n\t\t\t\t
\n\t\t\t\n\t\t\t\n

Limitations and Technical Notes<\/h2>\n

It is important for research teams working with DSIP to understand its pharmacokinetic properties:<\/p>\n